Russell Investments Group Ltd. lowered its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 62.5% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 56,569 shares of the company’s stock after selling 94,270 shares during the period. Russell Investments Group Ltd. owned approximately 0.10% of Nu Skin Enterprises worth $4,439,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. State Treasurer State of Michigan grew its stake in shares of Nu Skin Enterprises by 13.3% in the second quarter. State Treasurer State of Michigan now owns 20,500 shares of the company’s stock worth $1,603,000 after acquiring an additional 2,400 shares in the last quarter. Trexquant Investment LP grew its stake in shares of Nu Skin Enterprises by 229.3% in the second quarter. Trexquant Investment LP now owns 15,750 shares of the company’s stock worth $1,231,000 after acquiring an additional 10,967 shares in the last quarter. Arizona State Retirement System grew its stake in shares of Nu Skin Enterprises by 15.2% in the second quarter. Arizona State Retirement System now owns 38,610 shares of the company’s stock worth $3,019,000 after acquiring an additional 5,088 shares in the last quarter. Eagle Boston Investment Management Inc. grew its stake in shares of Nu Skin Enterprises by 4.4% in the second quarter. Eagle Boston Investment Management Inc. now owns 129,368 shares of the company’s stock worth $10,115,000 after acquiring an additional 5,444 shares in the last quarter. Finally, Greenleaf Trust acquired a new position in shares of Nu Skin Enterprises in the second quarter worth $216,000. Institutional investors and hedge funds own 76.01% of the company’s stock.
In related news, General Counsel D Matthew Dorny sold 3,500 shares of the business’s stock in a transaction on Monday, July 2nd. The shares were sold at an average price of $77.65, for a total value of $271,775.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Joseph Y. Chang sold 10,600 shares of the business’s stock in a transaction on Thursday, August 9th. The shares were sold at an average price of $82.13, for a total transaction of $870,578.00. Following the completion of the sale, the insider now directly owns 63,416 shares of the company’s stock, valued at $5,208,356.08. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 43,850 shares of company stock valued at $3,589,888. Corporate insiders own 5.20% of the company’s stock.
Several equities analysts have commented on NUS shares. Zacks Investment Research upgraded shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $95.00 price target for the company in a research note on Monday, August 6th. Jefferies Financial Group started coverage on shares of Nu Skin Enterprises in a research report on Thursday, June 14th. They set a “buy” rating and a $98.00 price objective for the company. ValuEngine cut shares of Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 6th. Finally, Stifel Nicolaus raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and lifted their price objective for the stock from $57.00 to $70.00 in a research report on Thursday, August 2nd. They noted that the move was a valuation call. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $85.33.
Nu Skin Enterprises stock opened at $83.61 on Monday. The firm has a market cap of $4.61 billion, a PE ratio of 25.89, a PEG ratio of 2.37 and a beta of 1.11. Nu Skin Enterprises, Inc. has a 12-month low of $59.31 and a 12-month high of $88.68. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.82 and a quick ratio of 1.19.
Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Thursday, August 2nd. The company reported $1.08 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.18. The business had revenue of $704.19 million during the quarter, compared to analysts’ expectations of $642.16 million. Nu Skin Enterprises had a net margin of 5.74% and a return on equity of 25.67%. The company’s revenue for the quarter was up 28.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.77 EPS. sell-side analysts forecast that Nu Skin Enterprises, Inc. will post 3.61 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 12th. Stockholders of record on Friday, August 31st were given a dividend of $0.365 per share. The ex-dividend date was Thursday, August 30th. This represents a $1.46 annualized dividend and a dividend yield of 1.75%. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 45.20%.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Recommended Story: Fundamental Analysis and Choosing Stocks
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.